Mankind Pharma makes audio recording of its Q4 & FY26 investor conference call available on its website.
The call was held on May 20, 2026, with senior management participation as previously intimated.
This disclosure is made pursuant to SEBI Listing Regulations compliance requirements.
No financial data or UPSI was disclosed in this specific announcement.